Who
Bret Christensen
Director
Company insider
Files Form 4 as: Chief Executive Officer, Biote; Chief Executive Officer, DermTech; EVP and CCO, Insulet.
In numbers
- Trades disclosed
- 49
- Buys
- 1
- Sells
- 4
- Bought
- $145K
- Sold
- $3.5M
- Companies
- 3
- Companies where not an officer
- 0
- First trade
- 26 May 2017
- Last trade
- 8 Jun 2026
- Last filed
- 10 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 8 Jun 2026filed 10 Jun 2026 | BTMD Bioteoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —130,000 at $0.00 | filing |
| 8 Jun 2026filed 10 Jun 2026 | BTMD Bioteoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —130,000 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | BTMD Bioteoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —441,653 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | BTMD Bioteoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —441,653 at $0.00 | filing |
| 17 Mar 2025filed 18 Mar 2025 | BTMD BiotePharmaceuticals | SEC FORM 4 Bought | $145K37,595 at $3.87 | filing |
| 1 Mar 2025filed 3 Mar 2025 | BTMD Bioteoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —1,500,000 at $0.00 | filing |
| 8 May 2023filed 10 May 2023 | DermTechoption or derivative | SEC FORM 4 Code A | —500,000 at $0.00 | filing |
| 28 Feb 2023filed 1 Mar 2023 | PODD Insuletoption or derivative · Medical Devices | SEC FORM 4 Code A | —5,419 at $0.00 | filing |
| 28 Feb 2023filed 1 Mar 2023 | PODD InsuletMedical Devices | SEC FORM 4 Code F | $96K349 at $276.36 | filing |
| 28 Feb 2023filed 1 Mar 2023 | PODD InsuletMedical Devices | SEC FORM 4 Code A | —2,261 at $0.00 | filing |
| 17 Feb 2023filed 21 Feb 2023 | PODD InsuletMedical Devices | SEC FORM 4 Code F | $45K153 at $296.00 | filing |
| 17 Feb 2023filed 21 Feb 2023 | PODD InsuletMedical Devices | SEC FORM 4 Code A | —3,108 at $0.00 | filing |
| 17 Feb 2023filed 21 Feb 2023 | PODD InsuletMedical Devices | SEC FORM 4 Code F | $308K1,041 at $296.00 | filing |
| 10 Feb 2023filed 13 Feb 2023 | PODD InsuletMedical Devices | SEC FORM 4 Code F | $59K199 at $294.83 | filing |
| 18 Nov 2022filed 21 Nov 2022 | PODD InsuletMedical Devices | SEC FORM 4 Sold | $885K3,000 at $295.15 | filing |
| 24 Aug 2022filed 25 Aug 2022 | PODD InsuletMedical Devices | SEC FORM 4 Sold | $766K2,900 at $264.24 | filing |
| 28 Feb 2022filed 2 Mar 2022 | PODD Insuletoption or derivative · Medical Devices | SEC FORM 4 Code A | —6,500 at $0.00 | filing |
| 28 Feb 2022filed 2 Mar 2022 | PODD InsuletMedical Devices | SEC FORM 4 Code A | —2,361 at $0.00 | filing |
| 26 Feb 2022filed 28 Feb 2022 | PODD InsuletMedical Devices | SEC FORM 4 Code F | $142K542 at $262.37 | filing |
| 18 Feb 2022filed 22 Feb 2022 | PODD InsuletMedical Devices | SEC FORM 4 Code A | —7,329 at $0.00 | filing |
News
Clover Health Investments (NASDAQ:CLOV) vs. biote (NASDAQ:BTMD) Financial AnalysisBTMD · themarketsdaily.com · 15 Oct 2026Hims & Hers Health (NYSE:HIMS) vs. biote (NASDAQ:BTMD) Head-To-Head ContrastBTMD · themarketsdaily.com · 10 Oct 2026
0 headlines in the last 90 days name Bret Christensen; 2 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.